Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients

Lignende værker

• Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer
  af: Mace, Thomas, et al.
  Udgivet: (2015)
• BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer
  af: Mace, Thomas, et al.
  Udgivet: (2014)
• Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer
  af: Mace, Thomas A., et al.
  Udgivet: (2015)
• IL-6 and PD-L1 antibody blockade combination therapy reduces tumor progression in murine models of pancreatic cancer
  af: Mace, Thomas A., et al.
  Udgivet: (2016)
• Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
  af: Mace, Thomas A., et al.
  Udgivet: (2013)